BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 16859405)

  • 1. Current views on the fundamental mechanisms of cytochrome P450 allosterism.
    Atkins WM
    Expert Opin Drug Metab Toxicol; 2006 Aug; 2(4):573-9. PubMed ID: 16859405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Allosterism" in the elementary steps of the cytochrome P450 reaction cycle.
    Yoon MY; Campbell AP; Atkins WM
    Drug Metab Rev; 2004 May; 36(2):219-30. PubMed ID: 15237852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-Michaelis-Menten kinetics in cytochrome P450-catalyzed reactions.
    Atkins WM
    Annu Rev Pharmacol Toxicol; 2005; 45():291-310. PubMed ID: 15832445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting drug pharmacokinetics in humans from in vitro metabolism studies.
    McGinnity DF; Riley RJ
    Biochem Soc Trans; 2001 May; 29(Pt 2):135-9. PubMed ID: 11356141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling cytochromes P450 binding modes to predict P450 inhibition, metabolic stability and isoform selectivity.
    Carosati E
    Drug Discov Today Technol; 2013; 10(1):e167-75. PubMed ID: 24050246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Designing better drugs: predicting cytochrome P450 metabolism.
    de Groot MJ
    Drug Discov Today; 2006 Jul; 11(13-14):601-6. PubMed ID: 16793528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human drug metabolism and the cytochromes P450: application and relevance of in vitro models.
    Venkatakrishnan K; Von Moltke LL; Greenblatt DJ
    J Clin Pharmacol; 2001 Nov; 41(11):1149-79. PubMed ID: 11697750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric behavior in cytochrome p450-dependent in vitro drug-drug interactions: a prospective based on conformational dynamics.
    Atkins WM; Wang RW; Lu AY
    Chem Res Toxicol; 2001 Apr; 14(4):338-47. PubMed ID: 11304120
    [No Abstract]   [Full Text] [Related]  

  • 9. Cytochrome P450-mediated metabolism in the human gut wall.
    Thelen K; Dressman JB
    J Pharm Pharmacol; 2009 May; 61(5):541-58. PubMed ID: 19405992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting drug clearance from recombinantly expressed CYPs: intersystem extrapolation factors.
    Proctor NJ; Tucker GT; Rostami-Hodjegan A
    Xenobiotica; 2004 Feb; 34(2):151-78. PubMed ID: 14985145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of cytochrome P450 mediated metabolism.
    Olsen L; Oostenbrink C; Jørgensen FS
    Adv Drug Deliv Rev; 2015 Jun; 86():61-71. PubMed ID: 25958010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human cytochromes P450 in the metabolism of drugs: new molecular models of enzyme-substrate interactions.
    Lewis DF; Ito Y
    Expert Opin Drug Metab Toxicol; 2008 Sep; 4(9):1181-6. PubMed ID: 18721112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of cytochrome P450-mediated drug clearance in humans based on the measured activities of selected CYPs.
    Gao J; Wang J; Gao N; Tian X; Zhou J; Fang Y; Zhang HF; Wen Q; Jia LJ; Zou D; Qiao HL
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29054967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the recognition of mammalian microsomal cytochrome P450 substrates and their characteristics: towards the prediction of human p450 substrate specificity and metabolism.
    Lewis DF
    Biochem Pharmacol; 2000 Aug; 60(3):293-306. PubMed ID: 10856424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cytochrome P450 isoenzymes in metabolism of endo- and exogenic compounds].
    Wiśniewska A; Mazerska Z
    Postepy Biochem; 2009; 55(3):259-71. PubMed ID: 19928582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterotropic cooperativity of cytochrome P450 3A4 and potential drug-drug interactions.
    Tang W; Stearns RA
    Curr Drug Metab; 2001 Jun; 2(2):185-98. PubMed ID: 11469725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications of the allosteric kinetics of cytochrome P450s.
    Atkins WM
    Drug Discov Today; 2004 Jun; 9(11):478-84. PubMed ID: 15149623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of human cytochrome P450 enzymes.
    Guengerich FP
    FASEB J; 1992 Jan; 6(2):745-8. PubMed ID: 1537465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flavokawain A inhibits Cytochrome P450 in in vitro metabolic and inhibitory investigations.
    Niu L; Ding L; Lu C; Zuo F; Yao K; Xu S; Li W; Yang D; Xu X
    J Ethnopharmacol; 2016 Sep; 191():350-359. PubMed ID: 27318274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fast regulation of cytochrome P450 activities by phosphorylation and consequences for drug metabolism and toxicity.
    Oesch-Bartlomowicz B; Oesch F
    Biol Chem; 2002 Oct; 383(10):1587-92. PubMed ID: 12452435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.